Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 8/20 | 0.57 |
| ▸ | CTSB | P07858 | 3/20 | 0.53 |
| ▸ | GRB2 | P62993 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | XIAP | P98170 | 1/20 | 0.43 |
| ▸ | DPP3 | Q9NY33 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.42 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.42 |
| ▸ | ANPEP | P15144 | 1/20 | 0.41 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.41 |
| ▸ | BDKRB2 | P30411 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29630498 | 0.96 | CAPN1 (0.51) | CAPN1CTSBGRB2SLC6A2XIAP | |
| SCHEMBL32689781 | 0.94 | CAPN1 (0.57) | CAPN1CTSBGRB2XIAP | |
| SCHEMBL29679608 | 0.90 | CAPN1 (0.49) | CAPN1CTSBGRB2SLC6A2XIAP | |
| SCHEMBL29630673 | 0.90 | CAPN1 (0.47) | CAPN1CTSBGRB2SLC6A2XIAP | |
| SCHEMBL30817467 | 0.89 | CAPN1 (0.61) | CAPN1CTSBGRB2SLC6A2XIAP | |
| SCHEMBL29630574 | 0.89 | CAPN1 (0.49) | CAPN1CTSBGRB2SLC6A2XIAP | |
| SCHEMBL29630674 | 0.88 | CAPN1 (0.53) | CAPN1CTSBGRB2SLC6A2XIAP | |
| SCHEMBL32689778 | 0.87 | CAPN1 (0.51) | CAPN1CTSBGRB2SLC6A2OPRM1 | |
| SCHEMBL32689776 | 0.87 | CAPN1 (0.51) | CAPN1CTSBGRB2SLC6A2OPRM1 | |
| SCHEMBL29396765 | 0.86 | CAPN1 (0.52) | CAPN1CTSBGRB2SLC6A2XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4039710-B1 | ANTI-CD3 ANTIBODIES, ANTI-CD123 ANTIBODIES AND BISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO CD3 AND/OR CD123 | SANOFI SA (FR) | 2026-03-25 | — | — | EP | disclosed |